Sevelamer ( DrugBank: Sevelamer )

2 diseases

ID	Disease name (Link within this page)	Number of trials
235	Hypoparathyroidism	1
238	Vitamin D-resistant rickets	1

235. Hypoparathyroidism

Clinical trials : 88 / Drugs : 107 - (DrugBank : 24) / Drug target genes : 5 - Drug target pathways : 7

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000000475	2006/07/01	01/09/2006	Therapeutic strategy of relative hypoparathyroidism in hemodialysis patients using sevelamer hydrochloride, with special reference to vitamin D administration	Therapeutic strategy of relative hypoparathyroidism in hemodialysis patients using sevelamer hydrochloride, with special reference to vitamin D administration - The effect of sevelamer hydrochloride on relative hypoparathyroidism in hemodialysis patients	Relative hypoparathyoidism in maintenance hemodialysis patients	Replacement of calcium carbonate with sevelamer hydrochloride as phosphate binder	Hokusetsu ROD Study Group	NULL	Complete: follow-up complete	20years-old	Not applicable	Male and Female	40	Not applicable	Japan

Clinical trials : 28 / Drugs : 20 - (DrugBank : 9) / Drug target genes : 3 - Drug target pathways : 16

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01057186 (ClinicalTrials.gov)	December 2009	26/1/2010	Hypophosphatemic Rickets in Norway	Hypophosphatemic Rickets in Norway	Hypophosphatemia, Familial;Rickets;Hyperphosphatemia	Dietary Supplement: Alfacalcidol; phosphate.;Drug: Sevelamer	Haukeland University Hospital	NULL	Active, not recruiting	N/A	N/A	Both	80	N/A	Norway